L. Ţugui

Efficacy and Safety of Ledispavir/Sofosbuvir with or without Ribavirin in patients with Decompensated Liver Cirrhosis and Hepatitis C Infection: a Cohort Study.

C. Preda, C. Meianu, M. Diculescu, 2020, Journal of gastrointestinal and liver diseases : JGLD.

Environmental Factors in Romanian and Belgian Patients with Inflammatory Bowel Disease - a Retrospective Comparative Study.

E. Louis, C. Preda, M. Diculescu, 2019, Maedica.

Efficacy of treatment with Ombitasvir, Paritaprevir / r + Dasabuvir over 8 versus 12 weeks in chronic HCV hepatitis genotype 1B

T. Stroie, C. Preda, M. Diculescu, 2021 .

Effectiveness of entecavir treatment and predictive factors for virologic response.

C. Preda, M. Diculescu, C. Băicuș, 2014, Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva.

Role of an Exclusion Diet (Reduced Disaccharides, Saturated Fats, Emulsifiers, Red and Ultraprocessed Meats) in Maintaining the Remission of Chronic Inflammatory Bowel Diseases in Adults

T. Stroie, C. Preda, M. Mănuc, 2023, Medicina.

Hepatitis Delta Virus Infection in Romania: Prevalence and Risk Factors.

I. Sporea, L. Gheorghe, C. Gheorghe, 2015, Journal of gastrointestinal and liver diseases : JGLD.

412 PREVALENCE, VIROLOGICAL AND CLINICAL CHARACTERISTICS OF CHRONIC HEPATITIS DELTA VIRUS INFECTION (CHD) IN ROMANIA

I. Sporea, I. Rogoveanu, S. Iacob, 2013 .

Infliximab for Crohn's disease in clinical practice: the experience of a single center in romania.

M. Badea, C. Preda, L. Gheorghe, 2003, Romanian journal of gastroenterology.

The efficacy of the Peginterferon treatment in chronic hepatitis HDV and compensate liver cirrhosis.

C. Preda, L. Gheorghe, M. Diculescu, 2014, Revista medico-chirurgicala a Societatii de Medici si Naturalisti din Iasi.

SARS-COV-2 infection might cause transient cutaneous lesions in IBD patients under treatment with adalimumab

C. Preda, M. Mănuc, I. Băncilă, 2021 .